%402x.svg)
Two Serums Supported by with AI Skin Diagnostics
Kao’s "SOFINA" line has traditionally been known as an accessible brand in Japan, famous for offering essential, dermatology-based skincare at affordable prices through popular lineups like SOFINA iP and Primavista. They have also previously invested in digital tools like the smartphone-based "Hada id" for skin analysis.
Building on this background, in January 2026, Kao launched "SOFINA SYNC+" as a next-generation D2C brand. This brand infuses their 1970s stratum corneum research with Kao's proprietary Sebum RNA Monitoring and AI technology - a cutting-edge analysis previously reserved for premium, limited initiatives but now commercialized for broader digital access.
To resolve the confusion around how this ecosystem operates: The diagnostic experience is powered by an in-house AI model integrated into "SOFINA Hada id" - Kao's established skin analysis tool used by approximately 800,000 consumers. Users simply take a smartphone photo, and the AI model (trained on actual sebum RNA data) estimates their skin type within 30 seconds, categorizing them into user-friendly Skin Gene Types (C1 or C2). However, the two newly released pre-serums tailored to these skin types are not available at traditional retail; they are sold exclusively via My Kao Mall, Kao’s dedicated e-commerce platform.
While there are no official plans to expand physical retail distribution, this setup highlights a clear strategic intent: Kao is leveraging a massive, built-in digital user base (via Hada id) to maximize consumer accessibility on the front end, while intentionally restricting product availability to My Kao Mall on the back end to drive direct-to-consumer (D2C) data gathering and brand loyalty.
Tackling Consumer Decision Fatigue
In the Japanese skincare market, many consumers struggle to choose products, feeling overwhelmed by information and uncertain about what genuinely suits their skin. Studies show that while consumers look for multiple benefits - such as efficacy, texture, gentleness, and cost-performance - they must ultimately rely on reading ingredients or checking online reviews.
SOFINA SYNC+ addresses this difficulty in assessing and verbalizing one’s own skin condition. Utilizing Kao’s extensive research in the stratum corneum and RNA, the brand uses AI analysis to visualize the skin's current state and presents a simplified two-type index called "Skin Gene Types."
The core insight of this initiative is how it tackles the consumer's decision fatigue. By introducing a clear, new criteria - determining whether you are C1 or C2 skin type - the brand directly connects its scientific research assets to the consumer's decision-making process, removing the friction from product selection.
Streamlining Evaluation to Product Selection
The main takeaway is the value of translating complex research into easy to understand criteria that helps reduce consumer confusion. Rather than simply push technical data, Kao focuses on easing the consumer's decision-making process by organizing information into a clear "C1 or C2" skin type framework.
For brands looking to apply this mindset in Japan, one potential direction is to rethink how their existing strengths (ingredients or technology) are communicated.
For instance, brands could consider developing unique, easy-to-understand labels or categories that help consumers identify which product line fits them best, combined with a simple diagnostic tool. Creating a seamless journey from analysis to product selection serves as a practical example of how a brand can eliminate shopping stress and build consumer trust.
